ReviewThe FEBS journal2021
Targeting neuropilins as a viable SARS-CoV-2 treatment.
Sarvenaz Sarabipour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewThe FEBS journal2021
Sarvenaz Sarabipour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.